Test Price
2,800 AED✅ Home Collection Available
MATN3 Gene Multiple Epiphyseal Dysplasia Type 5 Genetic Test in UAE | AED 2,800 | 2026 DHA Guidelines
تحليل جين MATN3 للكشف عن خلل التنسج المشاشي المتعدد من النوع الخامس في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
اختبار جيني معتمد من هيئة الصحة بدبي بدقة تشخيصية 99.9%، مع خدمة سحب الدم المنزلي الفاخرة عبر سلسلة تبريد معتمدة ISO، وتوجيه سريري هاتفي بعد النتائج، وتحقق مباشر من التغطية التأمينية عبر واتساب.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview: MATN3 Gene & Multiple Epiphyseal Dysplasia Type 5
This next‑generation sequencing test comprehensively analyses the MATN3 gene for mutations associated with multiple epiphyseal dysplasia type 5, a rare autosomal dominant skeletal disorder characterised by early‑onset joint pain and malformations. يقدم هذا الاختبار تحليلاً جينياً شاملاً لجين MATN3 للكشف عن الطفرات المرتبطة بخلل التنسج المشاشي المتعدد من النوع الخامس، مما يساعد في التشخيص والإرشاد الوراثي.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | NGS (Massively Parallel Sequencing) | Single‑gene Sanger |
| Coverage | All coding exons, splice sites & CNV detection | Selected exons only |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Clinical Sensitivity | 99.9% | ~95% (limited to point mutations) |
Physician Insight & Safety Protocol
“As a genetic medicine specialist, I emphasise that while this test provides definitive molecular information, clinical correlation with detailed skeletal surveys and family history remains paramount. A negative MATN3 result does not exclude other forms of epiphyseal dysplasia; ongoing clinical follow‑up is essential. Please discuss all findings with your consulting physician.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠ Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- • Exclusion: Active infection at phlebotomy site; inability to give informed consent (testing for minors requires parental consent per UAE CDS Law).
- • Exclusion: Pregnancy – risk‑free, but requires specialised genetic counselling before sampling.
- • Red Flag: Sudden severe joint effusion, locking, or inability to bear weight – seek immediate orthopaedic care; this test is not an emergency diagnostic tool.
- • Red Flag: High fever or systemic signs – may indicate unrelated acute illness; postpone elective genetic sampling.
Frequently Asked Questions
What is the MATN3 gene test for?
The MATN3 Genetic Test detects pathogenic mutations in the MATN3 gene causing multiple epiphyseal dysplasia type 5, aiding in diagnosis, family planning, and management. The test is recommended for individuals with early‑onset joint pain, stiffness, and skeletal abnormalities, as well as at‑risk relatives. يكشف اختبار جين MATN3 عن الطفرات المرضية المسببة لخلل التنسج المشاشي المتعدد من النوع الخامس، مما يساعد في التشخيص والتخطيط العائلي.
How is the sample collected, and is it painful?
A simple blood draw or a finger‑prick dried blood spot on an FTA card is performed by our certified phlebotomist during home collection, ensuring minimal discomfort. For infants, a heel‑prick alternative is available; all procedures follow strict aseptic technique. يتم سحب عينة دم بسيطة أو بقعة دم جافة على بطاقة FTA بواسطة أخصائي معتمد، مع أقل قدر من الانزعاج.
When will I receive my results?
Results are typically available within 3 to 4 weeks, and post‑ counselling is provided to explain the findings in plain language. Urgent preliminary reports can be requested for time‑sensitive clinical decisions. تظهر النتائج عادةً في غضون 3 إلى 4 أسابيع، مع جلسة إرشاد وراثي هاتفية لشرح النتائج بلغة واضحة.
Compliant with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), Child Data Sovereignty Law 2026, and UAE PDPL. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA facility license 9834453. All genetic data encrypted and stored within UAE borders.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians